866-997-4948(US-Canada Toll Free)

Psoriatic Arthritis-Market Insights, Epidemiology and Market Forecast-2025

Published By :

DelveInsight

Published Date : Jul 2017

Category :

Pharmaceutical

No. of Pages : 70 Pages

DelveInsights Psoriatic Arthritis -Market Insights, Epidemiology and Market Forecast-2025 report provides an overview of the disease and in depth research related to Psoriatic Arthritis for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Psoriatic Arthritis . It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Psoriatic Arthritis for 7 major markets.

The market outlook also provides understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products. Additionally, the Report highlights the frontrunners, the drivers and barriers for the Psoriatic Arthritis market, as well as treatment algorithm, current treatments & advancements are included.The chapters including marketed products highlights the advantages and disadvantages associated with therapies associated with Psoriatic Arthritis , providing an in-depth analysis of emerging therapies which will create an impact through their launch.

According to DelveInsight, the forecasted patient population of Psoriatic Arthritis for the year 2025 will be XX, increasing at a CAGR of XX% from 2015 to 2025 and the Psoriatic Arthritis 7MM market size is estimated to be USD XX by 2025.The DelveInsight Report will help in enhanced understanding of the Psoriatic Arthritis market from inside out, with transparency into the calculated patient forecasting data and estimated market size.

Key Coverage

Understanding historical and forecasted epidemiological data for Psoriatic Arthritis covering 7MM from 2015-2025.
Segment level epidemiology and market split for Psoriatic Arthritis .
The thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Psoriatic Arthritis .
The Report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and Japan) from 2015-2025 and detailed historical and forecasted Psoriatic Arthritis market trends.
Thorough market distribution based on market share for Psoriatic Arthritis .

Reasons to buy

The report will help in developing business strategies by understanding trends shaping and driving the Psoriatic Arthritis market.
To understand the future market competition in the Psoriatic Arthritis market and Insightful review of the key market drivers and barriers.
Organize sales and marketing efforts by identifying the best opportunities for Psoriatic Arthritis in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.
Identification of strong upcoming players in market will help in devising strategies that will help in getting ahead of competitors.


1. Report Introduction
2. Psoriatic Arthritis Market Overview at a Glance
2.1. Total Market Share Distribution of Psoriatic Arthritis for 7 MM in 2016
2.2. Total Market Share Distribution of Psoriatic Arthritis for 7 MM in 2025
3. Psoriatic Arthritis
3.1.1. Overview
3.1.2. Symptoms
3.1.3. Pathophysiology
3.1.4. Staging
3.1.5. Diagnosis
3.1.6. Treatment
4. Epidemiology and Patient Population
4.1.1. United States
4.1.1.1. Diagnosed Cases of Psoriatic Arthritis in United States
4.1.2. Germany
4.1.2.1. Diagnosed Cases of Psoriatic Arthritis in Germany
4.1.3. France
4.1.3.1. Diagnosed Cases of Psoriatic Arthritis in France
4.1.4. Italy
4.1.4.1. Diagnosed Cases of Psoriatic Arthritis in Italy
4.1.5. Spain
4.1.5.1. Diagnosed Cases of Psoriatic Arthritis in Spain
4.1.6. United Kingdom
4.1.6.1. Diagnosed Cases of Psoriatic Arthritis in United Kingdom
5. Treatment Algorithm
5.1.1. Treatment Guidelines/Practices
6. Marketed Drugs for Psoriatic Arthritis
6.1. Drug 1: Company A
6.1.1. Drug Description
6.1.2. Mechanism of Action
6.1.3. Regulatory Milestones
6.1.4. Advantages & Disadvantages
6.1.5. Safety and Efficacy
6.1.6. Product Profile
6.1.7. Patent Status
6.2. Drug 2: Company B
6.2.1. Drug Description
6.2.2. Mechanism of Action
6.2.3. Regulatory Milestones
6.2.4. Advantages & Disadvantages
6.2.5. Safety and Efficacy
6.2.6. Product Profile
6.2.7. Patent Status
7. Emerging Therapies
7.1. Drug 3: Company C
7.1.1. Description
7.1.2. Regulatory Milestones
7.1.3. Advantages & Disadvantages
7.1.4. Product Profile
7.1.5. Launch Date
7.1.6. Clinical Development
7.1.7. Clinical Pipeline Activity
7.1.8. Ongoing Trials Information
7.1.9. Clinical Trial by Phase
7.2. Drug 4: Company B
7.2.1. Description
7.2.2. Regulatory Milestones
7.2.3. Advantages & Disadvantages
7.2.4. Product Profile
7.2.5. Launch Date
7.2.6. Clinical Development
7.2.7. Clinical Pipeline Activity
7.2.8. Ongoing Trials Information
7.2.9. Clinical Trial by Phase
8. Overview of Total Psoriatic Arthritis Market (2016 & 2025)
9. Psoriatic Arthritis : Country-Wise Market Analysis
9.1. United States
9.1.1. Historical Market Size (2015-2016)
9.1.2. Forecasted Market Size (2017-2025)
9.2. Germany Market Size
9.2.1. Historical Market Size (2015-2016)
9.2.2. Forecasted Market Size (2017-2025)
9.3. France Market Size
9.3.1. Historical Market Size (2015-2016)
9.3.2. Forecasted Market Size (2017-2025)
9.4. United Kingdom Market Size
9.4.1. Historical Market Size (2015-2016)
9.4.2. Forecasted Market Size (2017-2025)
9.5. Spain Market Size
9.5.1. Historical Market Size (2015-2016)
9.5.2. Forecasted Market Size (2017-2025)
9.6. Italy Market Size
9.6.1. Historical Market Size (2015-2016)
9.6.2. Forecasted Market Size (2017-2025)
9.7. Japan Market Size
9.7.1. Historical Market Size (2015-2016)
9.7.2. Forecasted Market Size (2017-2025)
10. Market Drivers
11. Market Restraints
12. Appendix
13. Report Methodology
14. Consulting Services
15. Disclaimer
16. About DelveInsight

List of Table

Table 1: Diagnosed Cases Psoriatic Arthritis in United States (2015-2025)
Table 2: Diagnosed Cases Psoriatic Arthritis in Germany (2015-2025)
Table 3: Diagnosed Cases Psoriatic Arthritis in France (2015-2025)
Table 4: Diagnosed Cases Psoriatic Arthritis in United Kingdom (2015-2025)
Table 5: Diagnosed Cases Psoriatic Arthritis in Spain (2015-2025)
Table 6: Diagnosed Cases Psoriatic Arthritis in Italy (2015-2025)
Table 7: Diagnosed Cases Psoriatic Arthritis in Japan (2015-2025)
Table 8: List of Marketed Drugs for Psoriatic Arthritis
Table 9: List of Pipeline Phase III Drugs for Psoriatic Arthritis
Table 10: Drug 1, Clinical Trials by Zone, 2017
Table 11: Clinical Trials by Trial status, 2017
Table 12: Drug 2, Clinical Trials by Zone, 2017
Table 13: Clinical Trials by Trial status, 2017
Table 14: Drug 3, Clinical Trials by Zone, 2017
Table 15: Clinical Trials by Trial status, 2017
Table 16: United States Market Size of Psoriatic Arthritis in USD, Million (2015-2025)
Table 17: Germany Market Size of Psoriatic Arthritis in USD, Million (2015-2025)
Table 18: France Market Size of Psoriatic Arthritis in USD, Million (2015-2025)
Table 19: United Kingdom Market Size of Psoriatic Arthritis in USD, Million (2015-2025)
Table 20: Spain Market Size of Psoriatic Arthritis in USD, Million (2015-2025)
Table 21: Italy Market Size of Psoriatic Arthritis in USD, Million (2015-2025)
Table 22: Japan Market Size of Psoriatic Arthritis in USD, Million (2015-2025)

List of Chart

July, 2017

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *